MEKanistic Therapeutics
PrivateLast Round
Grant
Aug 1, 2023
Total Funding Raised
$914,319
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MEKanistic Therapeutics operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Grant round in August 2023.
MEKanistic Therapeutics is a biotechnology company that develops innovative kinase inhibitors for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MEKanistic Therapeutics Comparables
Compare MEKanistic Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OnKure Therapeutics | 77% | |
| BlossomHill Therapeutics | 71% | |
| ORIC Pharmaceuticals | 66% |
For institutional investors. Book with your work email.
MEKanistic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2023 | ||||
| VC Round | Jul 25, 2022 | ||||
| Grant | Feb 15, 2018 | ||||
| Grant | Apr 20, 2017 | ||||
| Grant | Feb 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MEKanistic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Invenshure | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 358% MoM.
- Feb 2, 2026
Monthly visitors increased 4847% MoM, from 15 to 742.
For institutional investors. Book with your work email.
MEKanistic Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MEKanistic Therapeutics's valuation, stock price, and market status.
Is MEKanistic Therapeutics a public or private company?
MEKanistic Therapeutics is a private company.
What is the current stock price of MEKanistic Therapeutics?
MEKanistic Therapeutics is a private company, so its shares have no public market price. Caplight tracks MEKanistic Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MEKanistic Therapeutics worth (valuation)?
Valuation information for MEKanistic Therapeutics is not publicly available.
Can I buy MEKanistic Therapeutics stock?
MEKanistic Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MEKanistic Therapeutics's last funding round?
MEKanistic Therapeutics's most recent funding round was Grant on August 1, 2023.
Who are the main investors in MEKanistic Therapeutics?
Key investors in MEKanistic Therapeutics include National Cancer Institute, NIH RADx, Invenshure.
Will MEKanistic Therapeutics IPO soon?
No public IPO plans have been announced for MEKanistic Therapeutics.
How can I track MEKanistic Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in MEKanistic Therapeutics's shares on secondary markets.